GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas
Robbie G. Majzner(Dana-Farber Cancer Institute), Michelle Monje(Howard Hughes Medical Institute)
Cited by 769
Related Papers
Functionally defined therapeutic targets in diffuse intrinsic pontine glioma
|Nature Medicine|2015|711
Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors
|Science Translational Medicine|2017|427
Pediatric high-grade glioma: biologically and clinically in need of new thinking
|Neuro-Oncology|2016|365